FDA Brief

Warning letters Drugs

FDA warning letter to

Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil

High riskIssued Feb 13, 2023Posted Feb 14, 2023Center for Drug Evaluation and Research | CDER

FDA warned Delta Kozmetik that its OTC drug products were adulterated due to CGMP violations.

What happened

FDA inspected the Delta Kozmetik drug manufacturing facility in Tuzla, Istanbul, from September 12 to September 16, 2022. The inspection found that the firm did not adequately test incoming components or qualify suppliers, did not validate manufacturing processes or qualify equipment, and lacked an adequate stability program. FDA said the firm’s October 7, 2022 response was inadequate and placed the firm on Import Alert 66-40 on January 11, 2023; it had been placed on Import Alert 66-78 on May 17, 2021, due to violative sampling results.

What FDA found

  1. The firm did not test each incoming component for identity and conformity with specifications before use, and it did not validate its suppliers’ test analyses.

    21 CFR 211.84(d)(1) and 211.84(d)(2)
  2. The firm lacked adequate written production and process control procedures and had not validated its manufacturing processes or qualified its equipment.

    21 CFR 211.100(a)
  3. The firm did not establish or follow an adequate stability testing program to support storage conditions and expiration dates.

    21 CFR 211.166(a)

What FDA wants

FDA tells the company to correct the violations promptly and respond in writing within 15 working days with what it has done and a schedule for any remaining actions. FDA also recommends engaging a qualified CGMP consultant.

Who should pay attention

  • U.S. importers and distributors of Delta Kozmetik OTC drugs
  • companies buying OTC drug products made by this Turkish manufacturer
  • supplier quality teams that rely on component certificates of analysis

This is a summary. Read the original letter on fda.gov.

Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil's FDA history

  1. Delta Kozmetik Sanayi Ve Ticaret-Selim Yesil

    FDA found Delta Kozmetik's hand sanitizer labeled with higher ethanol was only 59% ethanol and refused import.

    High risk

Full company page

Similar letters to other companies

  1. Natural Essentials, Inc.

    FDA warns Natural Essentials over OTC drug manufacturing violations, including inadequate failing test result investigations and missing component identity tests.

    High risk
  2. Shenzhen Benliju Biotech Co., Ltd.

    FDA: Shenzhen Benliju Biotech released OTC drugs labeled sterile without sterility testing or process validation.

    High risk
  3. LGM Pharma Solutions, LLC

    FDA warned LGM Pharma Solutions over manufacturing-quality failures in failing-result investigations and process validation for tablets, including a recalled product.

    High risk
  4. Penn Herb Company, Ltd.

    FDA warned Penn Herb Company over CGMP violations and an undeclared tree-nut allergen in three dietary supplements.

    High risk